Lv4
650 积分 2022-12-19 加入
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
5个月前
已完结
Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines
9个月前
已完结